Editorial
|
|
|
Emphasis on patients' best interests
|
|
|
New Products
|
|
|
Too many questions about long-term adverse effects
|
|
|
|
|
|
|
|
Only when G-CSF stem cell motilisation fails
|
|
|
|
|
|
|
Just another TNT alpha antagonist, no advantage
|
|
|
|
|
|
|
Adverse Effects
|
|
|
Dealing with uncertainties
|
|
|
|
|
|
|
|
A single course of antenatal corticosteroids is safer
|
|
|
|
|
|
Use the INN to avoid such errors
|
|
|
|
|
|
|
|
Reviews
|
|
|
Organised screening is best
|
|
|
|
|
|
|
|
|
Antibiotic therapy depending on the clinical context
|
|
|
|
|
|
|
No more effective than placebo
|
|
|
|
|
|
Not for cancer or cardiovascular prevention
|
|
|
|
|
|
|
|
|
|